Ensign Peak Advisors’s Sana Biotechnology SANA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-72,050
| Closed | -$300K | – | 1724 |
|
|
2024
Q3 | $300K | Buy |
72,050
+4,000
| +6% | +$16.6K | ﹤0.01% | 1675 |
|
|
2024
Q2 | $372K | Buy |
+68,050
| New | +$372K | ﹤0.01% | 1662 |
|
|
2023
Q1 | – | Sell |
-164,638
| Closed | -$650K | – | 1786 |
|
|
2022
Q4 | $650K | Sell |
164,638
-9,503
| -5% | -$37.5K | ﹤0.01% | 1509 |
|
|
2022
Q3 | $1.05M | Sell |
174,141
-130,318
| -43% | -$782K | ﹤0.01% | 1043 |
|
|
2022
Q2 | $1.96M | Sell |
304,459
-72,751
| -19% | -$468K | ﹤0.01% | 810 |
|
|
2022
Q1 | $3.12M | Sell |
377,210
-4,983
| -1% | -$41.2K | 0.01% | 721 |
|
|
2021
Q4 | $5.92M | Sell |
382,193
-234
| -0.1% | -$3.62K | 0.01% | 616 |
|
|
2021
Q3 | $8.61M | Sell |
382,427
-6,362
| -2% | -$143K | 0.02% | 471 |
|
|
2021
Q2 | $7.64M | Buy |
388,789
+18
| +0% | +$354 | 0.02% | 507 |
|
|
2021
Q1 | $13M | Buy |
+388,771
| New | +$13M | 0.03% | 372 |
|